Latest News

circassia_grass_allergy_peptide_spire_trial

UK Immunotherapy against Grass Allergies moves on to Phase III Trials

Circassia is beginning a Phase III trial for its short-course immunotherapy for grass allergies. This common type of allergy can significantly impact the life quality of patients. Circassia is based in Oxford (UK) and was part of 2014’s record Biotech …

READ MORE →
Springwave_spirulina_algae_microalgae_biotech_drink_hong_kong_facebook_drink_algama

Asian Super investor claims stake in Microalgae Drink Startup

The French startup Algama has received €3.5M investment from the Hong Kong billionaire, Li Ka-shing, known for his stakes in Facebook, Spotify and Skype. Based on a microalgae brew, Algama’s nutritional drinks product SpringWave is evidently hitting the marketing mark, by making the algae Spirulina a …

READ MORE →
david_schilansky_dbv_coo_labiotech

DBV Technologies: “This is our First and most Significant Partnership signed”

The billion-euro Biotech from Paris DBV Technologies just signed a €100M deal with Nestlé Health Science to develop a new diagnostic test of Milk allergies. This is the first deal of DBV and shows the potential of its technological platform. …

READ MORE →
roche_diabetes_senseonics_fluorescent_sensor

Roche debuts new MedTech for needle-free management of Diabetes

Roche is making progress in its Diabetes Care unit. It has struck a deal with the MedTech company Senseonics to sell an implantable glucose sensor in some major European countries. The Diabetes Care division of Swiss big Pharma Roche has more …

READ MORE →
bionnale2016

Besides Techno, Berlin is also the place to be for Life Science Industries

On the 25th of May, the largest network event for life sciences and healthcare industries in the German capital region once again came to life for the 14th time, for Bionnale 2016 . As we too belong to this city, we are pleased to summarise …

READ MORE →
carbios_bioplastic_bio_recycling_biodegradation

French Biodegradable Plastics get 2 new key US Patents

Carbios has been granted two key US patents: One for a novel plastic-degrading microorganism, and another for the creation of plastics with a customised lifespan – which could help bioplastics break into more industrial applications. A Green Chemistry company from …

READ MORE →
nasdaq_merus_biotech_ipo_closing_immunooncology_cancer_breast_ovarian_colorectal_finance

Dutch Immuno-Oncology Biotech closes massive IPO on the NASDAQ

The Utrecht based Merus has snagged around $47.3M (€42.5M) in an IPO on the NASDAQ market for its portfolio of antibodies targeting breast and colorectal cancers. Back in April 2015, Merus announced its intention to go public on the Nasdaq, …

READ MORE →
hot-air_pixabay_labiotech_week

What Happened this Week? Refresh, Virtual Biotech, Bayer and Monsanto

1. So that was Labiotech Refresh! Here are the conference Highlights 2. To Be – or Not To Be, a Virtual Biotech? 3. Bayer offers Big Buy out for the infamous Monsanto. Shareholders are not pleased… 4. Even after Quarantine, Ebola still …

READ MORE →
blood_cancer_biotech_car-t_antibodies

It’s Blood Cancer Day, how is Biotech fixing it?

Today is the World Blood Cancer Day, an event to show solidarity to patients and raise awareness for the need of better therapies to treat these cancers – which are still often deadly. Blood cancers can affect different type of cells …

READ MORE →
pharnext_biotech_week_header

Biotech of the Week: Pharnext, developing next level drugs against Alzheimer’s and Parkinson’s disease

The Scandinavian charm is wonderful but this week we are (finally) heading back to Central Europe. Do I really need to say what happens in Paris? We all know that: The Eiffel Tower, the Louvre, the pretty sights, la Seine and it’s …

READ MORE →
morphosys_md_anderson_cancer_ylanthia_immuno-oncology

Top German Biotech joins World-renowned center for Cancer Research

MorphoSys joins the list of European partners of MD Anderson Cancer Center, one of the world’s most respected oncology institutions. The long-term alliance will look into novel antibodies against cancer. MorphoSys is a leading German Biotech, well-known for its focus in …

READ MORE →
qiagen_therawis_diagnostics_chemotherapy_tnbc

Qiagen partners up for Novel Diagnostic against Breast Cancer

Qiagen is partnering up with Therawis to develop a diagnostic test to predict how effective an aggressive chemotherapy will be in patients with high risk breast cancer. A giant in molecular diagnostics, Qiagen is now working in a new diagnostic …

READ MORE →

Inside Labiotech

labiotech_refresh_biotech_crispr_immunotherapy_berlin_gene_startup_conference_pharma

So that was Labiotech Refresh…now here’s the Conference Highlights in Hi-Def!

Our Summary video is ready and rolling. Here’s a little of what it was like on the day – including some awesome testimonials from some of the speakers, including Celyad, VenomAb and Genenta. I already wrote a recap of the …

READ MORE →
labiotech_refresh_startup_conference_may_berlin_biotech_startup_highlights

So that was Labiotech Refresh! Here are the conference Highlights

So after months of planning our first biotech conference, it’s kind of surreal to think it’s actually over. For now, anyway! Here’s a recap of the day; speakers, panels, audience and the team, as we put together the premier of Labiotech’s Conference …

READ MORE →

Event Planning

Don't miss the hottest European Biotech News!